It's called Micra is only the size of a capsule, 93 percent smaller than a traditional pacemaker, and weighs just 2 grams, making it the world's smallest pacemaker. It can be implanted in the heart in a minimally invasive way, and the smart glucose monitoring system is only the size of a seashell, wearable and warnable.Micra is small but has a strong battery life, with the compatibility of 1.5 T (Tesla) / 3.0 T whole-body nuclear magnetic *** vibration scanning inspection, and other innovative features, to provide patients with arrhythmia with a stable life kinetic energy.
The number of arrhythmia patients in China exceeds more than 10 million , and the incidence of arrhythmia is rapidly increasing as China enters an aging society. Arrhythmia brings multiple physical and economic pressures to patients and their families, and at the same time, the growing population of patients also poses a huge challenge to the national healthcare system. Pacemakers can help patients improve heart function and enable the heart to pump blood regularly, ensuring the blood needs of patients' major organs.
Professor: ? Implanting a pacemaker is the only effective treatment for non-reversible bradycardia. Today finally ushered in the world's smallest leadless pacemaker into clinical application in China at the Expo, realizing the synchronous development with international counterparts in the level of medical technology. The number of arrhythmia patients benefiting from pacemaker therapy in China each year has increased by more than 30 times compared with the time when pacemaker therapy was introduced just three decades ago, and the breakthroughs in cutting-edge innovations in pacemaker therapy have met the growing demand for cardiac healthcare services from the general public.
Professor Zhang Shu emphasized: ? Micra empowers medical technology with the concept of human-centered technology, innovates surgical methods, improves patient prognosis, reduces overall treatment costs, and achieves an organic balance between accessibility and affordability of therapies, opening a new era of leadless pacing for the treatment of cardiac arrhythmias in China.
Then how to improve the patient benefit this? The last kilometer of medical insurance?
How to improve the patient benefit of this ?